Cara Therapeutics Stock (NASDAQ: CARA) stock price, news, charts, stock research, profile.
Open | $0.758 |
Close | $0.716 |
Volume / Avg. | 194.721K / 592.084K |
Day Range | 0.712 - 0.775 |
52 Wk Range | 0.500 - 4.670 |
Market Cap | $39.754M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 5.55% |
Days to Cover | 7.26 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cara Therapeutics (NASDAQ: CARA) through any online brokerage.
Other companies in Cara Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC) and Ocuphire Pharma (NASDAQ:OCUP).
The latest price target for Cara Therapeutics (NASDAQ: CARA) was reported by Needham on Wednesday, April 10, 2024. The analyst firm set a price target for 5.00 expecting CARA to rise to within 12 months (a possible 587.57% upside). 16 analyst firms have reported ratings in the last year.
The stock price for Cara Therapeutics (NASDAQ: CARA) is $0.7272 last updated May 10, 2024 at 6:55 PM EDT.
There are no upcoming dividends for Cara Therapeutics.
Cara Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Cara Therapeutics.
Cara Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.